News tagged with rhabdomyosarcoma
Novel cancer gene accelerates or stops tumour growth
May 27, 2009 |
not rated yet |
0
(PhysOrg.com) -- Researchers at the Hospital for Sick Children (SickKids) and the University of Toronto have found a gene that plays a crucial role in the development of rhabdomyosarcoma - the most common childhood sarcoma ...
Search results for rhabdomyosarcoma
Study links molecule to muscle maturation, muscle cancer
Dec 30, 2008 |
not rated yet |
0
Researchers at The Ohio State University Comprehensive Cancer Center have discovered that a molecule implicated in leukemia and lung cancer is also important in muscle repair and in a muscle cancer that strikes ...
Pediatric cancer stem cell identified: understanding the origin of ERMS
May 17, 2007 |
5 / 5 (1) |
0
As published in the June 1 issue of Genes & Development, Dr. Leonard Zon (Children’s Hospital Boston) and colleagues have identified the cancer stem cell for rhabdomyosarcoma, the most common soft-tissue sarcoma of childh ...
Mature Muscle Fibers Can Revert to Become Cancerous
Sep 01, 2006 |
4.1 / 5 (7) |
0
Mature muscle fibers, rather than their less-developed neighbors, are the tissues that turn malignant in a soft-tissue cancer that strikes children and teens, researchers at UT Southwestern Medical Center and Children’s Medical ...
Mutated FGFR4 protein helps a childhood cancer spread
Oct 05, 2009 |
not rated yet |
0
Rhabdomyosarcoma (RMS) is a childhood cancer thought to originate from skeletal muscle. In patients whose disease has spread (metastasized) from the initial tumor site the chance of long-term survival is poor. Hopes for a ...
Expression of a membrane protein in peripheral tissue linked to cancer: A novel tumour marker
Oct 09, 2006 |
3.7 / 5 (3) |
0
Researchers at the Max Planck Institute of Experimental Medicine, in collaboration with the Department of Pathology at the Medical School of the Georg August University in Gottingen and the National Institute ...
Novel anticancer strategy moves from laboratory to clinic
Jan 03, 2008 |
4.8 / 5 (14) |
0
Researchers at Emory University have developed a novel anti-tumor compound that represents a distinct strategy: targeting one of the most important "intercept points" for cancer cells.
List of search results for rhabdomyosarcoma
